Skip to main content

lung cancer Archives

Algorithm scours health records for lung cancer risk

Aug. 15, 2023—Vanderbilt researchers have developed a computer algorithm that scans electronic health records, or EHRs, to identify patients who meet criteria for lung cancer screening.

Read more


Genomic analysis of SCLC tumors reveals subtypes, offers cues toward personalized treatments

May. 11, 2023—The largest genomic analysis ever conducted of small cell lung cancer tumors (SCLC) has identified genetic subtypes and provided insights into the mechanisms of this aggressive and deadly cancer.

Read more


Sandler named co-chair of ACR’s Lung Cancer Screening Steering Committee

Mar. 30, 2023—Vanderbilt's Kim Sandler, MD, has been named co-chair of the Lung Cancer Screening Steering Committee for the American College of Radiology.

Read more


Improving lung nodule diagnosis

Mar. 27, 2023—Adding blood and imaging biomarkers to a clinical prediction model could improve diagnostic accuracy for the 1.6 million lung nodules detected each year, many through expanded lung cancer screening programs.

Read more


Novel lung cancer biomarker

Jan. 9, 2023—Autoantibodies against the p53 tumor suppressor protein may be a novel biomarker for identifying people, especially African Americans, at high risk for lung cancer.

Read more


Lovly receives Asclepios Award from GO2 for Lung Cancer

Dec. 8, 2022—Vanderbilt's Christine Lovly, MD, PhD, has received the 2022 Asclepios Award, which recognizes lung cancer research pioneers.

Read more


Event set to make lung cancer screening more accessible

Oct. 20, 2022—Vanderbilt University Medical Center is making the lung cancer screening more convenient with weekend appointments from 8 a.m. to noon on Saturday, Nov. 12, at Vanderbilt Health One Hundred Oaks

Read more


Policy, resources crucial for lung cancer screening: study

Sep. 29, 2022—Vanderbilt reseach shows that resources for lung cancer screening programs increased the number of veterans screened.

Read more


Lung cancer detection program lands grant renewal

Sep. 15, 2022—The National Cancer Institute has renewed funding for the Early Detection Research Network Lung Cancer Clinical Validation Center at Vanderbilt- Ingram Cancer Center.

Read more


Targeted cancer drug during pregnancy

Aug. 2, 2022—The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.

Read more


H. pylori and lung cancer

Aug. 1, 2022—Specific biomarkers for H. pylori — a bacterium that infects the stomach — were associated with increased risk of lung cancer, Vanderbilt researchers have discovered.

Read more


Study reveals need for matching targeted therapies with EGFR subtypes

Jul. 28, 2022—A Vanderbilt study suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more